Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs J Scheltema

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Research and Reports in Urology|October 17, 2018
Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50Ilan Gielchinsky, Matthijs J Scheltema, Thomas Cusick, et al.
BMC Urology|March 3, 2022
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomesAlexandar Blazevski, William Gondoputro, Matthijs J Scheltema, et al.
BMC Urology|April 28, 2023
The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancerPaul Doan, Athos Katelaris, Matthijs J Scheltema, et al.
BJU International|August 11, 2017
Focal irreversible electroporation as primary treatment for localized prostate cancerWillemien van den Bos, Matthijs J Scheltema, Amila R Siriwardana, et al.
BJU International|August 24, 2017
Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancerMatthijs J Scheltema, Willemien van den Bos, Amila R Siriwardana, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Treatment Outcomes from <sup>68</sup>Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PETLouise Emmett, Pim J van Leeuwen, Rohan Nandurkar, et al.
BJU International|January 3, 2023
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancerBart Geboers, Matthijs J Scheltema, Alexandar Blazevski, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|September 14, 2018
Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segmentsMatthijs J Scheltema, John I Chang, Willemien van den Bos, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|August 24, 2017
Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedbackMatthijs J Scheltema, Arnoud W Postema, Daniel M de Bruin, et al.
European Urology Focus|November 6, 2017
Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible ElectroporationMatthijs J Scheltema, John I Chang, Willemien van den Bos, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Research and Reports in Urology|October 17, 2018
Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50Ilan Gielchinsky, Matthijs J Scheltema, Thomas Cusick, et al.
BMC Urology|March 3, 2022
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomesAlexandar Blazevski, William Gondoputro, Matthijs J Scheltema, et al.
BMC Urology|April 28, 2023
The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancerPaul Doan, Athos Katelaris, Matthijs J Scheltema, et al.
BJU International|August 11, 2017
Focal irreversible electroporation as primary treatment for localized prostate cancerWillemien van den Bos, Matthijs J Scheltema, Amila R Siriwardana, et al.
BJU International|August 24, 2017
Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancerMatthijs J Scheltema, Willemien van den Bos, Amila R Siriwardana, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Treatment Outcomes from <sup>68</sup>Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PETLouise Emmett, Pim J van Leeuwen, Rohan Nandurkar, et al.
BJU International|January 3, 2023
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancerBart Geboers, Matthijs J Scheltema, Alexandar Blazevski, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|September 14, 2018
Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segmentsMatthijs J Scheltema, John I Chang, Willemien van den Bos, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|August 24, 2017
Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedbackMatthijs J Scheltema, Arnoud W Postema, Daniel M de Bruin, et al.
European Urology Focus|November 6, 2017
Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible ElectroporationMatthijs J Scheltema, John I Chang, Willemien van den Bos, et al.
Pageof 4